Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот ресурс: http://elar.urfu.ru/handle/10995/130967
Полная запись метаданных
Поле DCЗначениеЯзык
dc.contributor.authorKrasnov, V. P.en
dc.contributor.authorNizova, I. A.en
dc.contributor.authorVigorov, A. Y.en
dc.contributor.authorMatveeva, T. V.en
dc.contributor.authorLevit, G. L.en
dc.contributor.authorKodess, M. I.en
dc.contributor.authorEzhikova, M. A.en
dc.contributor.authorSlepukhin, P. A.en
dc.contributor.authorBakulin, D. A.en
dc.contributor.authorTyurenkov, I. N.en
dc.contributor.authorCharushin, V. N.en
dc.date.accessioned2024-04-05T16:36:34Z-
dc.date.available2024-04-05T16:36:34Z-
dc.date.issued2023-
dc.identifier.citationKrasnov, V, Nizova, I, Vigorov, A, Matveeva, T, Levit, G, Kodess, M, Ezhikova, M, Slepukhin, P, Bakulin, D, Tyurenkov, I & Charushin, V 2023, 'Synthesis and Assessment of Antiplatelet and Antithrombotic Activity of 4-Amino-Substituted 5-Oxoproline Amides and Peptides', Molecules, Том. 28, № 21, 7401. https://doi.org/10.3390/molecules28217401harvard_pure
dc.identifier.citationKrasnov, V., Nizova, I., Vigorov, A., Matveeva, T., Levit, G., Kodess, M., Ezhikova, M., Slepukhin, P., Bakulin, D., Tyurenkov, I., & Charushin, V. (2023). Synthesis and Assessment of Antiplatelet and Antithrombotic Activity of 4-Amino-Substituted 5-Oxoproline Amides and Peptides. Molecules, 28(21), [7401]. https://doi.org/10.3390/molecules28217401apa_pure
dc.identifier.issn1420-3049-
dc.identifier.otherFinal2
dc.identifier.otherAll Open Access, Gold, Green3
dc.identifier.otherhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85176608417&doi=10.3390%2fmolecules28217401&partnerID=40&md5=52faeb3a24c5a45fe6a0f264f3a46c601
dc.identifier.otherhttps://www.mdpi.com/1420-3049/28/21/7401/pdf?version=1698979636pdf
dc.identifier.urihttp://elar.urfu.ru/handle/10995/130967-
dc.description.abstractVenous thromboembolism is a serious problem because it significantly increases the risk of developing vascular complications in elderly patients with obesity or immobilization, cancer, and many other diseases. Thus, there is a need to study new therapeutic strategies, including new medicinal agents for the efficient and safe correction of thrombus disorders. In this work, we have synthesized a number of new amides and peptides of 4-amino-5-oxoprolines and studied their antiplatelet and antithrombotic activity in experiments in vitro and in vivo. It has been found that the newly obtained compounds slow down the process of thrombus formation in a model of arterial and venous thrombosis, without affecting plasma hemostasis parameters. (2S,4S)-4-Amino-1-(4-fluorophenyl)-5-oxoprolyl-(S)-phenylalanine proved to be the most efficient among the studied derivatives. The results obtained indicate the advisability of further studies on 5-oxoproline derivatives in order to design pharmaceutical agents for the prevention and treatment of the consequences of thrombosis. © 2023 by the authors.en
dc.description.sponsorshipMinistry of Science and Higher Education of the Russian Federation: 075-15-2020-777en
dc.description.sponsorshipThis research was funded by the Ministry of Science and Higher Education of Russia (agreement no. 075-15-2020-777 of 1 October 2020).en
dc.format.mimetypeapplication/pdfen
dc.language.isoenen
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.rightscc-byother
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/unpaywall
dc.sourceMolecules2
dc.sourceMoleculesen
dc.subject5-OXOPROLINEen
dc.subjectAMIDESen
dc.subjectHISTIDINEen
dc.subjectIN VIVO EXPERIMENTSen
dc.subjectMORPHOLINEen
dc.subjectPEPTIDESen
dc.subjectPHENYLALANINEen
dc.subjectPIPERIDINEen
dc.subjectPYROGLUTAMIC ACIDen
dc.subjectAMIDEen
dc.subjectANTITHROMBOCYTIC AGENTen
dc.subjectFIBRINOLYTIC AGENTen
dc.subjectPEPTIDEen
dc.subjectPYROGLUTAMIC ACIDen
dc.subjectAGEDen
dc.subjectCHEMISTRYen
dc.subjectHUMANen
dc.subjectTHROMBOSISen
dc.subjectAGEDen
dc.subjectAMIDESen
dc.subjectFIBRINOLYTIC AGENTSen
dc.subjectHUMANSen
dc.subjectPEPTIDESen
dc.subjectPLATELET AGGREGATION INHIBITORSen
dc.subjectPYRROLIDONECARBOXYLIC ACIDen
dc.subjectTHROMBOSISen
dc.titleSynthesis and Assessment of Antiplatelet and Antithrombotic Activity of 4-Amino-Substituted 5-Oxoproline Amides and Peptidesen
dc.typeArticleen
dc.typeinfo:eu-repo/semantics/articleen
dc.type|info:eu-repo/semantics/publishedVersionen
dc.identifier.doi10.3390/molecules28217401-
dc.identifier.scopus85176608417-
local.contributor.employeeKrasnov, V.P., Postovsky Institute of Organic Synthesis, Russian Academy of Sciences (Ural Branch), Ekaterinburg, 620108, Russian Federationen
local.contributor.employeeNizova, I.A., Postovsky Institute of Organic Synthesis, Russian Academy of Sciences (Ural Branch), Ekaterinburg, 620108, Russian Federationen
local.contributor.employeeVigorov, A.Y., Postovsky Institute of Organic Synthesis, Russian Academy of Sciences (Ural Branch), Ekaterinburg, 620108, Russian Federationen
local.contributor.employeeMatveeva, T.V., Postovsky Institute of Organic Synthesis, Russian Academy of Sciences (Ural Branch), Ekaterinburg, 620108, Russian Federationen
local.contributor.employeeLevit, G.L., Postovsky Institute of Organic Synthesis, Russian Academy of Sciences (Ural Branch), Ekaterinburg, 620108, Russian Federationen
local.contributor.employeeKodess, M.I., Postovsky Institute of Organic Synthesis, Russian Academy of Sciences (Ural Branch), Ekaterinburg, 620108, Russian Federationen
local.contributor.employeeEzhikova, M.A., Postovsky Institute of Organic Synthesis, Russian Academy of Sciences (Ural Branch), Ekaterinburg, 620108, Russian Federationen
local.contributor.employeeSlepukhin, P.A., Postovsky Institute of Organic Synthesis, Russian Academy of Sciences (Ural Branch), Ekaterinburg, 620108, Russian Federationen
local.contributor.employeeBakulin, D.A., Laboratory of Pharmacology of Cardiovascular Agents, Scientific Center for Innovative Medicines, Volgograd State Medical University, Volgograd, 400131, Russian Federationen
local.contributor.employeeTyurenkov, I.N., Laboratory of Pharmacology of Cardiovascular Agents, Scientific Center for Innovative Medicines, Volgograd State Medical University, Volgograd, 400131, Russian Federationen
local.contributor.employeeCharushin, V.N., Postovsky Institute of Organic Synthesis, Russian Academy of Sciences (Ural Branch), Ekaterinburg, 620108, Russian Federation, Chemical Engineering Institute, Ural Federal University, Ekaterinburg, 620002, Russian Federationen
local.issue21-
local.volume28-
dc.identifier.wos001099550100001-
local.contributor.departmentPostovsky Institute of Organic Synthesis, Russian Academy of Sciences (Ural Branch), Ekaterinburg, 620108, Russian Federationen
local.contributor.departmentLaboratory of Pharmacology of Cardiovascular Agents, Scientific Center for Innovative Medicines, Volgograd State Medical University, Volgograd, 400131, Russian Federationen
local.contributor.departmentChemical Engineering Institute, Ural Federal University, Ekaterinburg, 620002, Russian Federationen
local.identifier.pure48542552-
local.description.order7401-
local.identifier.eid2-s2.0-85176608417-
local.identifier.wosWOS:001099550100001-
local.identifier.pmid37959820-
Располагается в коллекциях:Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Файлы этого ресурса:
Файл Описание РазмерФормат 
2-s2.0-85176608417.pdf2,57 MBAdobe PDFПросмотреть/Открыть


Лицензия на ресурс: Лицензия Creative Commons Creative Commons